Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders

Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders

US Patent 9155784 · Granted Oct 13, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for activating signaling through the CB1 cannabinoid re2025
Compositions and methods for activating signaling through the CB1 cannabinoid re2024
Therapeutic acid ceramidase compositions and methods of making and using them2021
Ceramidase and cell differentiation2019
Ceramidase and cell differentiation2019
Therapeutic acid ceramidase compositions and methods of making and using them2019
Dose escalation enzyme replacement therapy for treating acid sphingomyelinase de2019
Ceramide levels in the treatment and prevention of infections2018
Therapeutic acid ceramidase compositions and methods of making and using them2018
Targeted protein replacement for the treatment of lysosomal storage disorders2017
Dose escalation enzyme replacement therapy for treating acid sphingomyelinase de2017
Ceramide levels in the treatment and prevention of infections2016